Forgot your password?
typodupeerror

+ - Big Pharma presses US to quash cheap drug production in India

Submitted by Anonymous Coward
An anonymous reader writes "Pharmaceutical Research and Manufacturers of America (PhRMA), are leaning on the United States government to discourage India from allowing the production and sale of affordable generic drugs to treat diseases such as cancer, diabetes, HIV/AIDS and hepatitis. India is currently on the U.S. government's Priority Watch List — countries whose practices on protecting intellectual property Washington believes should be monitored closely. Last year Novartis lost a six-year legal battle after the Indian Supreme court ruled that small changes and improvements to the drug Glivec did not amount to innovation deserving of a patent. Western drugmakers,Pfizer, GlaxoSmithKline, Novartis, Roche Holding, Sanofi, and others have a bigger share of the fast-growing drugs market in India. But they have been frustrated by a series of decisions on patents and pricing, as part of New Delhi's push to increase access to life-saving treatments where only 15 percent of 1.2 billion people are covered by health insurance.

One would certainly understand and probably agree with the need for for cheaper drugs. But, don't forget that big pharma for all it's problems still is the number one creator of new drugs. In 2012 alone, the US government and private companies spent a combined total of $130 billion on medical research."
This discussion was created for logged-in users only, but now has been archived. No new comments can be posted.

Big Pharma presses US to quash cheap drug production in India

Comments Filter:

"Marriage is low down, but you spend the rest of your life paying for it." -- Baskins

Working...